ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch
ActiveUID / VAT
CHE-209.784.395 MWST
Commercial Register Number
CH-440-1038220-9
Seat
Kreuzlingen
Purpose
Entwicklung innovativer medizinischer Diagnose- und Behandlungskonzepte für Tumorerkrankungen.
Management
AI-generated contentJoin Our Beta Program
We are actively developing the platform. Sign up for beta access to get exclusive early access to new features.
Publications
05/22/2024
03/25/2022
Frequently Asked Questions
What is the legal status of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is Active in the Swiss Commercial Register.
What is the UID (VAT) number of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
The UID (VAT) number of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is CHE-209.784.395.
Where is ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch located?
ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is located in Kreuzlingen with its registered address at Eichhornweg 1, 8280 Kreuzlingen.
What is the legal form of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is registered as a Sole proprietorship (SP) in Switzerland.
What is the purpose of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
Entwicklung innovativer medizinischer Diagnose- und Behandlungskonzepte für Tumorerkrankungen.